Cancer

All Items

• 

  Fc fragment of IgG binding protein is correlated with immune infiltration levels in hepatocellular carcinoma

  Yuhong Suo, Chunyu Hou, Guang Yang, Hongfeng Yuan, Lina Zhao, Yufei Wang, Ningning Zhang, Xiaodong Zhang, Wei Lu

  605–615
• 

  Systemic analysis of the expression and prognostic significance of USP31 in endometrial cancer

  Yuzhen Huang, Peng Jiang, Yuting Chen, Jinyu Wang, Rui Yuan

  426–436
• 

  C5aR1 shapes a non-inflammatory tumor microenvironment and mediates immune evasion in gastric cancer

  Honghong Shen, Xianhua Gu, Xinwei Li, Zheng Xiang, Rong Zhang, Fan Shi, Mingyue Tang, Huiyuan Li, Guangzheng Zhu, Fang Su, Zishu Wang

  392–404
• 

  A prognostic nomogram for predicting overall survival in colorectal mucinous adenocarcinoma patients based on the SEER database

  Qian Wu, Suqin Zhang, Huan Wang, Yifei Zeng, Wei Yang, Wenjun Pan, Guodai Hong, Wenbin Gao

  517–526
• 

  Identification of RUNX1 and IFNGR2 as prognostic-related biomarkers correlated with immune infiltration and subtype differentiation of low-grade glioma

  Xia Zhang, Hongyu Chu, Yuan Cheng, Jie Ren, Wei Wang, Xicheng Liu, Xiaodong Yan

  405–425
• 

  Promotive role of USP29-mediated deubiquitination in malignant proliferation of colorectal cancer cells via the KIAA1429/SOX8 axis

  Juncai Li, Jianguo Yang, Zhenzhou Chen, Li Liu, Hao Wang, Qican Deng, Yajun Chen, Yong Que, Zhongxue Fu

  483–495
• 

  Effect of vascular endothelial growth factor rs35569394 in esophageal cancer and response to chemotherapy

  Zishan Wang, Chenwei Li, Xinjian Li, Jianguang Shi, Weijie Wu

  271–276
• 

  Efficacy and safety of PEG-rhG-CSF in preventing chemoradiotherapy-induced neutropenia in patients with locally advanced cervical cancer

  Weiwei Li, Mohan Dong, Shigao Huang, Liu Shi , Hua Yang, Ying Zhang, Jie Gong, Mei Shi, Lichun Wei, Lina Zhao

  310–316
• 

  Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study

  Elina Beleva, Snezhana Stoencheva, Tanya Deneva, Ivanka Nenova, Zhanet Grudeva-Popova

  287–297
• 

  Development and validation of radiomics machine learning model based on contrast-enhanced computed tomography to predict axillary lymph node metastasis in breast cancer

  Jieqiu Zhang, Gaofei Cao, Haowen Pang, Jin Li, Xiaopeng Yao

  317–326
• 

  Clinical features and outcomes of fusion gene defined adult Ph-negative B-cell precursor acute lymphoblastic leukemia patients: A single institutional report

  Kai Sun, Jun Wang, Wen-Min Chen, Nan Xu, Ling-Yu Long, Xu Wang, Hao Jiang, Qian Jiang, Xiao-Jun Huang, Ya-Zhen Qin

  298–309
• 

  Intrinsic resistance and efficacy of immunotherapy in microsatellite instability-high colorectal cancer: A systematic review and meta-analysis

  Ren Wang, Jie Lian, Xin Wang, Xiangyi Pang, Benjie Xu, Shuli Tang, Jiayue Shao, Haibo Lu

  198–208
• 

  Sacituzumab govitecan expands its therapeutic spectrum among breast cancer subtypes

  Semir Vranic

  189–190
• 

  VHL tumor suppressor as a novel potential candidate biomarker in papillary thyroid carcinoma

  Lidija Todorović, Boban Stanojević

  26-36
• 

  Prognostic and predictive significance of VEGF, CD31, and Ang-1 in patients with metastatic clear cell renal cell carcinoma treated with first-line sunitinib

  Marija Kraljević, Inga Marijanović, Maja Barbarić, Emir Sokolović, Merima Bukva, Timur Cerić, Teo Buhovac

  161-169
• 

  Guidelines for breast cancer management in Bosnia and Herzegovina

  Lejla Hadžikadić-Gušić, Timur Cerić, Inga Marijanović, Ermina Iljazović, Dijana Koprić, Anela Zorlak, Mahira Tanović, Alma Mekić-Abazović, Ibrahim Šišić, Una Delić, Jasminka Mustedanagić-Mujanović, Alija Aginčić, Edin Bećiragić, Frederick Greene

  2-14
• 

  Methylation pattern of caveolin-1 in prostate cancer as potential cfDNA biomarker

  Lucija Škara, Tonći Vodopić, Ivan Pezelj, Irena Abramovic, Borna Vrhovec, Alen Vrtarić, Nino Sincic, Davor Tomas, Stela Bulimbašić, Tomislav Kuliš, Monika Ulamec

  176-186
• 

  Relationship between PD-L1 expression and prognostic factors in high-risk cutaneous squamous and basal cell carcinoma

  Özden Yülek, Şebnem Batur, Kerem Özcan, Cansu Yol, Övgü Aydın Ülgen

  894-900
• 

  PLCE1 is a poor prognostic marker and may promote immune escape from osteosarcoma by the CD70-CD27 signaling pathway

  Linhai Huang, Chundi Liao, Hanhua Wu, Piwei Huang

  992-1004
• 

  Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy

  Zhaopei Guo, Zian Wang, Ruifeng Liang, Huayu Tian, Xuesi Chen, Meiwan Chen

  934-948